Figure 3.
Effect of ABT therapy on ADAM17 level in RA patients Serum was obtained from patients at baseline and after 24 weeks of ABT therapy. A significant reduction in serum ADAM17 level was observed after ABT treatment (*p<0.05).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.